McKinsey Settles Opioid Crisis Charges for $650 Million
TL;DR
Consulting firm McKinsey has agreed to pay $650 million to settle charges related to its role in the US opioid crisis, where it allegedly conspired with Purdue Pharma to misbrand prescription drugs. The settlement includes a deferred prosecution agreement, requiring McKinsey to reform its practices. This follows previous settlements totaling nearly $1 billion over similar allegations. The opioid crisis has led to nearly 100,000 overdose deaths annually in the US.
Topics:top-newsbusiness#business#mckinsey#opioid-crisis#purdue-pharma#settlement#us-department-of-justice
- McKinsey to pay $650m to settle opioid charges BBC.com
- McKinsey & Company to pay $650 million for role in opioid crisis NPR
- Why does McKinsey still get hired? The Guardian
- News Wrap: Consulting firm to pay $650 million for helping Purdue Pharma sell opioids PBS NewsHour
- McKinsey & Company to pay $650 million to settle opioid consulting probe, ex-partner to plead guilty CNBC
Want the full story? Read the original reporting
Read on BBC.com